This article is part of the supplement: VIII Madrid Breast Cancer Conference: Latest Advances in Breast Cancer
Developing a prediction model for benefit from fulvestrant in heavily pretreated metastatic breast cancer patients
Breast Cancer Research 2009, 11(Suppl 1):P29 doi:10.1186/bcr2312
Accesses
- Last 30 days: 11 accesses
- Last 365 days: 138 accesses
- All time: 434 accesses